Press Releases Onconetix, Inc.

Equities

ONCO

US09610B1089

End-of-day quote Nasdaq Other stock markets 03:30:00 23/05/2024 am IST			5-day change	1st Jan Change
0.1414 ^USD	-7.58%		+5.92%	-28.59%

20/05	Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
11/04	Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oncopeptides AB - First patients in Spain to be treated with Pepaxti	28/05	AQ
Immunovia Publishes Interim Report for January-March 2024	29/04	AQ
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors	13/02	AQ
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	31/01	AQ
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders	19/12	AQ
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	18/12	AQ
Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company	02/11	AQ
Blue Water Biotech : Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company - Form 8-K	02/11	PU
Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)	01/11	AQ
Blue Water Biotech Issues Letter to Shareholders	30/23/30	AQ
Blue Water Biotech : GENERAL RELEASE OF CLAIMS - Form 8-K	10/23/10	PU
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO	10/23/10	AQ
Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q	29/23/29	AQ
Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial Products	10/23/10	AQ
Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	01/23/01	AQ
Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians	31/23/31	AQ
Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®	25/23/25	AQ
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities	17/23/17	AQ
Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support	11/23/11	AQ
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products	07/23/07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Onconetix, Inc.

Equities

ONCO

US09610B1089

Press Releases

Filters